71 related articles for article (PubMed ID: 24382243)
1. [Expression of mitogen activated protein kinase phosphatase-1 in pancreatic cancer].
Guo JC; Shen SJ; Zhao YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Dec; 35(6):645-8. PubMed ID: 24382243
[TBL] [Abstract][Full Text] [Related]
2. [Down regulation of mitogen activated protein kinase phosphatase-1 mediate acquired multidrug resistance in pancreatic adenocarcinoma cell line SW1990/Fu].
Guo JC; Zhao YP; Liao Q; Chen G; Zhu Y
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):473-5. PubMed ID: 16772084
[TBL] [Abstract][Full Text] [Related]
3. COMP is selectively up-regulated in degenerating acinar cells in chronic pancreatitis and in chronic-pancreatitis-like lesions in pancreatic cancer.
Liao Q; Kleeff J; Xiao Y; Di Cesare PE; Korc M; Zimmermann A; Büchler MW; Friess H
Scand J Gastroenterol; 2003 Feb; 38(2):207-15. PubMed ID: 12678339
[TBL] [Abstract][Full Text] [Related]
4. Preferential expression of cystein-rich secretory protein-3 (CRISP-3) in chronic pancreatitis.
Liao Q; Kleeff J; Xiao Y; Guweidhi A; Schambony A; Töpfer-Petersen E; Zimmermann A; Büchler MW; Friess H
Histol Histopathol; 2003 Apr; 18(2):425-33. PubMed ID: 12647793
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
Rojo F; González-Navarrete I; Bragado R; Dalmases A; Menéndez S; Cortes-Sempere M; Suárez C; Oliva C; Servitja S; Rodriguez-Fanjul V; Sánchez-Pérez I; Campas C; Corominas JM; Tusquets I; Bellosillo B; Serrano S; Perona R; Rovira A; Albanell J
Clin Cancer Res; 2009 May; 15(10):3530-9. PubMed ID: 19417026
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
[TBL] [Abstract][Full Text] [Related]
7. Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis.
Maruyama H; Kleeff J; Wildi S; Friess H; Büchler MW; Israel MA; Korc M
Am J Pathol; 1999 Sep; 155(3):815-22. PubMed ID: 10487839
[TBL] [Abstract][Full Text] [Related]
8. [Preferential expression of cartilage oligomeric matrix protein in degenerating acinar cells in chronic pancreatitis and in chronic pancreatitis-like lesions].
Liao Q; Zhao YP; Kleeff J; Xiao Y; Zimmermann A; Buchler MW; Friess H
Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):328-31. PubMed ID: 12892583
[TBL] [Abstract][Full Text] [Related]
9. [The expression of MKP-1 and p-ERK(1/2) in primary ovarian epithelial tumor tissues].
Zhou JW; Gan NY; Zhang WJ
Fen Zi Xi Bao Sheng Wu Xue Bao; 2009 Jun; 42(3-4):224-30. PubMed ID: 19697705
[TBL] [Abstract][Full Text] [Related]
10. Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.
Denkert C; Schmitt WD; Berger S; Reles A; Pest S; Siegert A; Lichtenegger W; Dietel M; Hauptmann S
Int J Cancer; 2002 Dec; 102(5):507-13. PubMed ID: 12432554
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.
Serini S; Trombino S; Oliva F; Piccioni E; Monego G; Resci F; Boninsegna A; Picci N; Ranelletti FO; Calviello G
Apoptosis; 2008 Sep; 13(9):1172-83. PubMed ID: 18679798
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.
Wang L; Friess H; Zhu Z; Graber H; Zimmermann A; Korc M; Reubi JC; Büchler MW
Clin Cancer Res; 2000 Feb; 6(2):566-71. PubMed ID: 10690540
[TBL] [Abstract][Full Text] [Related]
13. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M
Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer.
Boutros T; Chevet E; Metrakos P
Pharmacol Rev; 2008 Sep; 60(3):261-310. PubMed ID: 18922965
[TBL] [Abstract][Full Text] [Related]
15. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
[TBL] [Abstract][Full Text] [Related]
16. The mitogen-activated protein kinase phosphatase-1 (MKP-1) gene is a potential methylation biomarker for malignancy of breast cancer.
Chen FM; Chang HW; Yang SF; Huang YF; Nien PY; Yeh YT; Hou MF
Exp Mol Med; 2012 May; 44(5):356-62. PubMed ID: 22333693
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M
Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448
[TBL] [Abstract][Full Text] [Related]
18. Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.
Masiero M; Minuzzo S; Pusceddu I; Moserle L; Persano L; Agnusdei V; Tosello V; Basso G; Amadori A; Indraccolo S
Leukemia; 2011 Apr; 25(4):588-98. PubMed ID: 21263446
[TBL] [Abstract][Full Text] [Related]
19. The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging.
Tai CJ; Wu AT; Chiou JF; Jan HJ; Wei HJ; Hsu CH; Lin CT; Chiu WT; Wu CW; Lee HM; Deng WP
BMC Cancer; 2010 Mar; 10():95. PubMed ID: 20226009
[TBL] [Abstract][Full Text] [Related]
20. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer.
Furukawa T; Sunamura M; Motoi F; Matsuno S; Horii A
Am J Pathol; 2003 Jun; 162(6):1807-15. PubMed ID: 12759238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
